A Study of Sargramostim Plus Pembrolizumab with or Without Pemetrexed in Patients with Advance Non-small Cell Lung Cancer After Completion of Chemoimmunotherapy

Clinical trial NCT04856176 · TERMINATED

Trial details

NCT number: NCT04856176
Sponsor: Tufts Medical Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Lung Non-Small Cell Carcinoma Non-Small Cell Carcinoma of Lung, TNM Stage 4

Start date: 2022-01-03
Primary completion: 2024-12-06
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.